Acute Myeloid Leukemia With Translocation (8;21) or Inversion (16) in Elderly Patients Treated With Conventional Chemotherapy: A Collaborative Study of the French CBF-AML Intergroup
Thomas Prébet(Yale University), Norbert Vey(Centre de Recherche en Cancérologie de Marseille), Mathilde Hunault(Centre National de la Recherche Scientifique), Emmanuelle Tavernier(Institute Cancer De La Loire Lucien Neuwirth), Christine Terré(Hôpital André Mignot), Christian Récher(Institut universitaire du cancer de Toulouse Oncopole), Sylvain Thépot(Centre Hospitalier Universitaire de Grenoble), Valérie Ugo(Inserm), Francis Witz(Centre Hospitalier Régional et Universitaire de Nancy), Jean‐Yves Cahn, S. Reutenauer(Centre Hospitalier Universitaire de Grenoble), Bruno Quesnel(Université de Lille), Benjamin Esterni(Centre Hospitalier Universitaire de Grenoble), Xavier Thomas(Hôpital Lyon Sud), Nicolas Boissel(Inserm), François Guilhot(Centre Hospitalier Universitaire de Poitiers), Jacques Delaunay(Hôtel-Dieu de Paris), Hervé Dombret(University of London Institute in Paris), Sylvie Castaigné(Hôpital André Mignot), Arnaud Pigneux(Centre Hospitalier Universitaire de Bordeaux)
Cited by 134
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k